Member Info for thetriplestar

The fundamentals have actually improved—they are transitioning from a pure explorer into an active producer with real US dollar revenue flowing in. But the massive share supply from the 0.60p placing has exhausted buying momentum for now. Until a major news catalyst lands (like a long-term multi-year offtake or a massive Tanzanian farm-out agreement), the price is simply consolidating and grinding through that cheap placing stock.

Because Monday’s data explicitly proved that SVN-002 targets a multi-billion-dollar U.S. market five times larger than Spravato, Solvonis has real leverage. Instead of issuing cheap stock to raise cash, they can leverage these results to sign a regional licensing or co-development partnership. A corporate partner can provide an upfront cash milestone payment to fund the Phase 2b trial, completely securing the runway without diluting a single share at rock-bottom prices.

A sophisticated Board doesn't dump shares into the open market at 0.19p to raise millions. Instead, they use data packages—like Monday's positive FDA bridging results—to secure a strategic cornerstone investor or a U.S. healthcare fund off-market. When a heavy-hitting institution takes a major stake, they often agree to a fixed placement price or even a premium because they are buying a massive block of shares that they couldn't acquire on the open market without driving the price up anyway.

I just hope that Nick knows what he is doing and that todays stock price is doubled by year end

While Raglan was heralded as ECR's first "turnkey" operational asset to generate near-term cash flow, the truth on the ground was far more fragile. By the time the deal closed in May, Raglan was coming off a mandatory wet-season pause and entering a trial-pit phase. It was far from a stable, high-volume cash cow. In fact, by June, they were still bringing in independent alluvial gold specialists just to optimise the wash plant because the recovery rates weren't where they needed to be. Nick absolutely would have known that relying on Raglan alone to pull A$2 million out of the ground in six months was a massive gamble.

Because Raglan’s production was slow and slim, the narrative almost immediately shifted. Management explicitly pivot-framed the strategy, admitting that Maddens (the hard-rock asset inherited from the Paleogold deal itself) is actually ECR's key near-term asset. They put A$1 million into extending the mine decline at Maddens, banking on an anticipated August completion to rapidly chase an estimated 2,500 ounces of gold to cover their debts.

11:11 a good sign

Do not be discouraged by today's flat response. The board didn't release this data to make the stock jump 50% today; they released it to lock in a higher price floor for the deal they are actively negotiating (IMO). They just proved their asset is world-class. The volume is churning, the weak hands are clearing out at 0.2p, and the runway is perfectly set for the real financial catalyst to land.

Expect a bloody Monday as the market clears out the noise, but keep your eyes firmly fixed on mid-week. The Board didn't fight for that legal ammunition on Friday just to sit on their hands all week.

If we do get that mid-week RNS, do you think they will lead with the SVN-001 Phase 3 data progress, or surprise the market with a direct U.S. institutional backing announcement?

Spot on. No board with this much skin in the game is going to willingly destroy their own equity by diluting at a basement circa 0.20p. You’re exactly right about the stepping stones; they cleared the legal floor at the AGM so they have the flexibility to drop value-driving news first. They won't pull the trigger while the barrel is at their head—the upcoming catalyst has to lift the share price out of the danger zone first, protecting both their investment and ours.

Fair point, and you're right that conditional deals happen all the time. But the real game-changer here is timing: under UK MAR, companies can legally delay disclosing ongoing, unsigned negotiations to avoid messing up the deal.

By using a regularly scheduled AGM to clear this 75% blanket headroom today, the board completely eliminated the standard 14-to-21-day administrative delay for a subsequent vote. Given our tight cash runway, they simply couldn't afford to wait. They loaded the weapon today so that when the ink finally dries on these background discussions, they can execute and announce a binding transaction instantly—and I have assumed this is a good thing given all considerations in this business.

In public markets, asking for a massive 75% share allotment without immediately using it to strengthen the company is incredibly dangerous for a Board. It leaves the share price exposed to retail panic and short-selling, because the market assumes dilution is constantly hanging over their heads. A sophisticated Board—especially one led by an experienced Wall Street veteran like Chairman Dennis Purcell—knows that you only trigger this kind of anxiety if you are prepared to kill the fear almost immediately with a massive, value-enhancing announcement.

The Board legally could not tell retail investors the exact details of why they needed this headroom before today. Under UK market abuse regulations, if a company is negotiating a massive corporate partnership, an institutional funding round, or a major grant with NIDA/NIAAA, that information is strictly classified as Inside Information. They cannot hint at it in an AGM notice. They have to pass the structural resolutions first, and then release the official RNS announcement detailing the deal. Next week perhaps?

You have hit on the exact golden rule of corporate finance theater...... Boards do not fight this hard for massive legal headroom unless the ink is already drying on a major development.

In public markets, companies don't build a massive 75% capital runway just to sit on it and watch the share price bleed; they do it because a specific, market-moving catalyst requires that structural space to be open right now.

Notice the specific emphasis in Chairman Dennis Purcell's statement: "...disciplined execution, capital-efficient development and creating long-term value for shareholders." This is classical Wall Street language designed to signal to large U.S. funds that the old, loose, high-cash-burn academic days are firmly in the past. The platform is now fully streamlined for commercial and regulatory velocity.

Yep loads of gold collecting down to that level of detail can melt that in to pure bars pretty easily - I think we in for a great ride with this one...

Nick didn't just put out a bad news RNS; he put out a fix. By immediately onboarding an independent alluvial specialist with 30 years of operational experience in Australia, he is intentionally accelerating the troubleshooting at Raglan. The board knows that fixing the water velocity and gravity jigs to catch that fine gold is the fastest way to turn the tap on.

In the interview, Nick dropped a major hint about how he views financing moving forward:

"The acquisition of Paleogold brought debt into ECR. This is not a structure suitable for pure exploration but, as our production capabilities grow, the opportunity to expand funding beyond traditional equity raises will also grow."

Because ECR now owns tangible, heavy mining equipment at Raglan and physical underground infrastructure at Maddens Flat, they have assets they can borrow against. If the company is short on cash come November, they do not automatically have to print cheap shares. They can secure a revolving credit facility, a gold streaming deal (selling future ounces at a discount for upfront cash), or standard asset-backed debt to clear that A$2 million hurdle.

While retail investors including Mr Coco, are hyper-focused on Raglan's wash plant, the real reason Nick signed that 6-month deadline is Maddens Flat.

As he stated in his interview, work on the underground decline is already well underway and expected to finish in August.

Maddens isn't an exploration project where they have to guess where the gold is; it is an existing historical asset with incredibly high grades (~14 g/t). Because the underground infrastructure is already being opened up, the plan is to dig directly into high-grade ore and monetise it immediately. If Maddens hits the ground running in September, it can generate cash far faster than a standard startup miner.

Absolutely. You have hit on the exact reason why the market’s reaction is so split right now. Nick Tulloch is a seasoned corporate financier; he would not sign his name to a legally binding obligation to find A$2 million in cash in 5 months' time unless he was staring at a math model that showed him exactly how to get it.

This is the classic "darkest before the dawn" phase of a micro-cap corporate transition. The London retail market is treating Solvonis like a dying UK trial, while the board is actively building a legal and promotional bridge to the U.S. market via Water Tower Research and federal grant pathways.

The next 10 days will be incredibly testing as we slide into the AGM, but the structural value of the 2043 patents and the clinical assets hasn't changed by a single fraction of a penny.